GIGA Carbon Neutrality Inc. (GCN) Signs Global Strategic Partnership With Carbon Trade eXchange (CTX)
12.5.2023 07:15:00 EEST | Business Wire | Press release
GIGA Carbon Neutrality Inc. (“GCN”) today announced the signing of a Strategic Partnership Agreement with London-based Carbon Trade eXchange (“CTX”) and its Australian technology parent company Global Environmental Markets (“GEM”) to globally expand CTX technology and trading.
This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20230511005848/en/
CTX has launched a White Label version of its carbon market technology. The partnership agreement will enable GCN to negotiate deals with carbon trading platforms and regular stock exchanges worldwide to provide buyers spot market access to carbon credits, RECs (Renewable Energy Certificates), and offsets. Thus, an AI and blockchain-technology-powered global carbon marketplace will be created featuring carbon futures contracts based on trusted high-quality carbon credits from hundreds of projects in multiple carbon registries. These include the UNFCCC CDM Registry, Verra VCS, and Gold Standard.
GCN undertakes to support the expansion of the licensing of GEM technology infrastructure for National Carbon Meta-Registries for nations to activate their commitments under the Paris Agreement and the creation of ITMOs or voluntary carbon credits like the recently launched Global Carbon Registry (GCR) and credit standard and the recently released Core Carbon Principles by the Integrity Council for voluntary carbon markets.
CTX, GEM, and GCN will work together to expand origination of voluntary credits globally and execute larger-scale trading of the credits, bringing together the GCN business and financial network with the 15 years of experience embedded in CTX and GEM’s “Technology Infrastructure for the Future of our Planet”.
The CEO of CTX, Wayne Sharpe, stated: “The current carbon markets must scale by a factor of 10 to 100X to reduce CO2 emissions globally and meet the Paris Agreement targets. Current registry infrastructure is insufficient.
Stock Exchanges globally are struggling to handle the unique carbon trading requirements in the voluntary markets – which deliver the much-needed Climate Finance via Carbon Credits. CTX will supply and support the required technology – then the buyers decide ”
The CEO of GCN, Richard Martin, added that “this Strategic Partnership Agreement is a big opportunity for GCN to use its extensive network of partners, affiliates, and investors to fast track our global expansion plans with a proven set of carbon technology infrastructure”.
About Carbon Trade eXchange (CTX): CTX is the world's first and leading Voluntary Carbon Exchange trading multiple credit standards and project types with transparent wholesale pricing. Trading out of HQ in London since 2008, CTX services over 500 members in more than 50 countries worldwide with T+0 trades online 24/7/365.
About Global Environmental Markets (GEM): GEM designs and develops environmental FinTech solutions including trading platforms, exchanges, registries, and interfaces. Headquartered in Australia GEM owns the CTX technology IP plus a suite of B2B / B2C solutions.
About GIGA Carbon Neutrality Inc. (GCN): GCN is a service and product integrator in the global intelligent commercial transportation and equipment market to efficiently realize customers’ carbon neutrality goals. GCN and its partners offer vehicle equipment manufacturing, comprehensive technologies, operation platforms, energy data and carbon credit services. For more information, please visit the website: https://gigacarbonneutrality.com/
To view this piece of content from cts.businesswire.com, please give your consent at the top of this page.
View source version on businesswire.com: https://www.businesswire.com/news/home/20230511005848/en/
Contact information
CTX/GEM:
Wayne Sharpe, info@ctxglobal.com, +447502229523, www.ctxglobal.com, www.gemglobal.com
GCN
Timothy Poor
Email: timothy.poor@gigacarbonneutrality.com
About Business Wire
For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
SLB Launches ExaCT Electrical Downhole CT Control System24.8.2026 14:02:00 EEST | Press release
SLB (NYSE: SLB) today launched the ExaCT™ electrical downhole coiled tubing (CT) control system, an advanced intervention platform that introduces real-time electrical control to coiled tubing operations. By replacing pressure-dependent hydraulic actuation with electrical communication, power delivery and telemetry, the ExaCT system gives operators greater visibility, precision and control, helping improve intervention execution and reservoir access. The ExaCT system combines electrical power, telemetry and downhole measurements to enable communication with, actuation of and verification of downhole tools throughout an intervention. Continuous communication across the toolstring enables on-demand tool actuation across a wide range of intervention applications, including extended-reach and multilateral wells. The increased precision and control provided by the system help operators optimize reservoir access, improve production performance and maximize recovery. "Operators are asking int
Wolters Kluwer Transforms Trusted Legal Content Into Structured, AI-Ready Intelligence That Powers the Next Wave of Legal AI24.8.2026 14:01:00 EEST | Press release
Wolters KluwerLegal & Regulatory today announced the next evolution of Libra by Wolters Kluwer, its all-in-one Legal AI Workspace. By transforming authoritative legal sources, expert commentaries, and practical guidance into structured legal intelligence, Wolters Kluwer is making the relationships across the full breadth of its expert legal sources more explicit. This will enable deeper contextual research, more comprehensible answers, and workflow-ready results across legal work. Following the integration of Wolters Kluwer content into the Libra AI workspace in the first half of 2026, laws, rulings, expert commentaries, and practical guidance will now be linked to one another and to the matter at hand, creating a connected knowledge graph of expert-curated and authoredlegal knowledge that AI can reason over. For customers, this means research that surfaces the right authority faster, answers with even clearer reasoning and sources, drafting guided by matter-specific context, and great
Daiichi Sankyo Appoints Markus Kosch to Lead Europe Business as Part of New Commercialization Organization24.8.2026 11:00:00 EEST | Press release
Daiichi Sankyo (TSE: 4568) today announced the appointment of Markus Kosch, MD, as Head of Europe Business, effective April 1, 2027. In this role, he will lead the company's European business within the new globally integrated Commercialization Unit and serve as General Manager of Daiichi Sankyo Europe GmbH, with legal responsibility for the company in Europe. The appointment reflects the next phase of growth of Daiichi Sankyo under its Five-Year Business Plan and the establishment of a new Commercialization Unit. Within this new structure, Markus Kosch will bring together the Oncology and Specialty businesses in Europe under one integrated leadership model to help bring innovative medicines to more patients across the region. For the past five years, Markus Kosch has led the Daiichi Sankyo Oncology Business Division in Europe and Canada, overseeing a period of significant growth and preparing the organization for an increasingly expanding oncology portfolio. Prior to joining Daiichi S
European Commission Approves DAYBU ® (trofinetide) as the First and Only Treatment for Neurobehavioral Symptoms of Rett Syndrome in the European Union24.8.2026 10:01:00 EEST | Press release
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced that the European Commission (EC) has granted marketing authorization for DAYBU (trofinetide) for the treatment of neurobehavioral symptoms of Rett syndrome in adults and pediatric patients aged five years and older, making it the first and only treatment approved for Rett syndrome in the European Union (EU). “The approval of DAYBU marks a significant milestone for the Rett syndrome community in the EU and advances our mission to bring this innovative treatment to patients and families who have long faced a profound unmet medical need,” said Catherine Owen Adams, Acadia’s Chief Executive Officer. “For people living with Rett syndrome, a devastating rare neurodevelopmental disorder, there have been no approved treatment options in the EU. We are proud to make DAYBU available and look forward to supporting patients, caregivers, and healthcare providers gain access to treatment." The DAYBU marketing authorization in the EU is prim
ORZEYFUL (oveporexton) Approved in Japan as the First and Only Medicine to Treat the Underlying Cause of Narcolepsy Type 124.8.2026 09:36:00 EEST | Press release
Takeda (TOKYO:4502/NYSE:TAK) announced that the Japanese Ministry of Health, Labour and Welfare (MHLW) approved the use of ORZEYFUL (oveporexton) for the treatment of narcolepsy type 1 (NT1, narcolepsy with cataplexy) in adults. ORZEYFUL is a first-in-class oral orexin receptor 2 (OX2R) agonist and the only medicine indicated in Japan to treat the disease holistically rather than individual symptoms. The discovery of this new class of medicine originated in Takeda's laboratories in Japan. Takeda is proceeding with launch preparations and expects to make ORZEYFUL available as quickly as possible. “Our discovery of the first orexin agonist is a successful representation of Japan-originated science that will directly impact people around the world living with narcolepsy type 1,” said Julie Kim, president and chief executive officer of Takeda. “With the potential to redefine narcolepsy type 1 care, ORZEYFUL is the first validation of our broader orexin strategy, demonstrating how scientifi
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom
